Exosens shares rebound 4.5% after an order for 25,000 tubes
The Bordeaux-based optronics specialist rebounded sharply mid-session, in a broadly stable Paris market. The move follows a decline that had pushed the stock away from its medium-term benchmarks, and comes as the group has just announced an order for image intensifier tubes.
A firm order for 25,000 tubes for Theon, with options attached
Exosens announced this Monday an initial order for image intensifier tubes, with options on an additional 35,000 units. The firm portion covers 25,000 tubes. The potential volume would reach 60,000 tubes if the options were exercised, which depends on the customer.
The stock is taking this order as a base after having broken below its support at €51.65 at the end of last week: the price of €53.20 has moved back above that level, with a 4.5% gain. Within the SBF 120, it ranks second, behind Vusion, while the index rises 0.11%.
A rebound that leaves the stock far from its moving averages
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Despite this recovery, the stock remains lower across several time frames: it has fallen 7.7% over one month and more than 20% over three months.
The price is below the MA20 (€55.19, a gap of 3.61%), the MA50 (€57.13) and the MA200 (€60.23, a gap of 11.67%), which highlights the distance still to cover to regain these benchmarks.
The RSI at 43 remains neutral and signals neither oversold nor overbought conditions. Over one year, the stock still shows a gain of 16%. The nearest resistance is at €61.10, that is above the MA200.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.